Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Analyzing the Health Effects of Space Travel with AI

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke  with host Tyler Kern about the movement collaboration…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke with host Tyler Kern about the movement collaboration between Intel and the Frontier Development Lab an applied artificial intelligence research accelerator established to maximize new AI technologies and capacities emerging in academia and space and exploration.

The Intel and Frontier Development Lab collaboration aims to improve the data collection of astronauts. The collaboration is working to make space exploration safer and healthier through artificial intelligence. “The collaboration with Intel rose organically. We were already applying AI and machine learning in the space, specifically for decision making,” says Dr. Kalantari.

“AI, when it comes to terrestrial medicine, is suffering from the same challenges as astronaut health and space medicine,” says Dr. Kalantari, who believes part of the issue is combining the health data of astronauts safely and securely into one database. “To train an AI, you have to bring together all the data into one spot and use that to train the algorithms,” says Shashi Jain.

The risk of spending time in space is detrimental to the human body. According to NASA, when astronauts are in microgravity, the human body loses muscle mass and bone density. Physically and psychologically, the impact on human bodies could be detrimental. The mission could fail if health issues hinder a crew member on a mission.

Currently, the effects on astronauts are similar to how we gather health information on earth. Data is collected through observation and measuring vitals. “We use this collection of data before, during, and after each mission to identify any prominent biomarkers that could be indicators of disease progression,” says Jain. The main challenge of the project is maintaining the privacy of the individuals so that the collected data can train AI for the future.

For more information on the power of technology and the future of astronaut health, connect with Shashi Jain and Dr. John Kalantari on LinkedIn or explore Intel’s Health and Life Sciences page.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Network & Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic have entered into a 10-year alliance focusing on ambient AI and its integration into electronic health records (EHR). This partnership aims to enhance healthcare delivery systems and streamline clinical processes through advanced technology.

  • 01Siemens Healthineers and Cleveland Clinic have formed a 10-year partnership to explore ambient AI in healthcare.
  • 02The alliance focuses on transforming electronic health records (EHR) with the integration of new AI technologies.
  • 03The partnership aims to improve healthcare delivery and streamline clinical processes.

Aug 9, 2026

A Physician Entrepreneur's Journey in Specialty Care Expansion - Dr. Joe Pazona, CEO of VirtuCare

Dr. Joe Pazona shares insights into his journey as a physician entrepreneur focusing on specialty care expansion. He highlights the challenges and strategies involved in growing a healthcare business. The discussion offers valuable lessons for other healthcare professionals looking to innovate and expand in their practices.

  • 01A physician entrepreneur focuses on specialty care expansion.
  • 02Innovative strategies are necessary for growth in healthcare businesses.
  • 03Lessons from healthcare leaders can help others in the industry.

Aug 8, 2026

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512